882188-88-7

Basic information

• Product Name: 1H-Indazole-1-carboxylic acid, 3-forMyl-, 1,1-diMethylethyl ester
• Synonyms: 1H-Indazole-1-carboxylic acid, 3-forMyl-, 1,1-diMethylethyl ester;tert-Butyl 3-formyl-1H-indazole-1-carboxylate;3-Formyl-indazole-1-carboxylic acid tert-butyl ester;3-Formyl-1H-indazol-1-carboxylic acid tert-butyl ester
• CAS NO: 882188-88-7
• Molecular Formula: C₁₃H₁₄N₂O₃
• Molecular Weight: 246.26186
• Mol File: 882188-88-7.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 390.3±34.0 °C(Predicted)
• Appearance: /
• Density: 1.20±0.1 g/cm3(Predicted)
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• PKA: -3.80±0.50(Predicted)
• CAS DataBase Reference: 1H-Indazole-1-carboxylic acid, 3-forMyl-, 1,1-diMethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Indazole-1-carboxylic acid, 3-forMyl-, 1,1-diMethylethyl ester(882188-88-7)
• EPA Substance Registry System: 1H-Indazole-1-carboxylic acid, 3-forMyl-, 1,1-diMethylethyl ester(882188-88-7)

Safety Data

• Hazardous Substances Data: 882188-88-7(Hazardous Substances Data)

Usage

General Description

1H-Indazole-1-carboxylic acid, 3-formyl-, 1,1-dimethylethyl ester is a chemical compound belonging to the class of organic compounds known as indazoles. Indazoles are polycyclic aromatic compounds containing a pyrazole ring fused to a benzene ring. This particular compound has an ester functional group, which is derived from carboxylic acids and alcohols, along with a formyl group, which is a functional group that consists of a carbonyl bonded to hydrogen. The "1,1-dimethylethyl" portion of its name indicates the presence of a tertiary butyl group. Its molecular formula is C15H17N2O3. Like many other organic compounds, it has potential applications in various research and industrial contexts, though specific information about this particular compound is limited.

Upstream product

• 882188-87-6 tert-butyl 3-(hydroxymethyl)-1H-indazole-1-carboxylate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 5235-10-9 1H-indazole-3-carboxaldehyde 
• 351457-12-0 1H-indazole-3-carboxylic acid methoxy(methyl)amide 
• 4498-67-3 1H-Indazole-3-carboxylic acid 
• 64132-13-4 3-(hydroxymethyl)-1H-indazole 

Downstream Products

• 936132-64-8 3-(2-benzyloxycarbonylamino-2-methoxycarbonyl-vinyl)-indazole-1-carboxylic acid tert-butyl ester 
• 1428969-58-7 1-(1H-indazol-3-yl)-2-((3-methoxyphenyl)amino)-2-phenylethanone 

Relevant articles and documents

GAMMA-DIKETONES AS WNT/BETA -CATENIN SIGNALING PATHWAY ACTIVATORS

The present disclosure provides γ-diketones or analogs thereof, that activate Wnt/β-catenin signaling and thus treat or prevent diseases related to signal transduction, such as osteoporosis and osteoarthropathy; osteogenesis imperfecta, bone defects, bone fractures, periodontal disease, otosclerosis, wound healing, craniofacial defects, oncolytic bone disease, traumatic brain injuries or spine injuries, brain atrophy/neurological disorders related to the differentiation and development of the central nervous system, including Parkinson's disease, strokes, ischemic cerebral disease, epilepsy, Alzheimer's disease, depression, bipolar disorder, schizophrenia; otic disorders like cochlear hair cell loss; eye diseases such as age related macular degeneration, diabetic macular edema or retinitis pigmentosa and diseases related to differentiation and growth of stem cell, such as hair loss, hematopoiesis related diseases and tissue regeneration related diseases.

New practical access to 2-azatryptophans and dehydro derivatives via the Wittig-Horner reaction

The Wittig-Horner reaction of protected 3-formylindazoles 1 with (±)-N-(benzyloxycarbonyl)-α-phosphonoglycine trimethyl ester 2 has been developed as a new practical synthesis of dehydro 2-azatryptophans and amino acid derivatives. The preparation of 5-br

Identification of a buried pocket for potent and selective inhibition of Chk1: Prediction and verification

Inhibition of the Chk1 kinase by small molecules binding to its active site is a strategy of great therapeutic interest for oncology. We report how computational modelling predicted the binding mode of ligands of special interest to the Chk1 ATP site, for representatives of an indazole series and debromohymenialdisine. These binding modes were subsequently confirmed by X-ray crystallography. The binding mode of a potent indazole derivative involves non-conventional C-H...O and N-H...π-aromatic interactions with the protein. These interactions are formed in a buried pocket at the periphery of the ATP-binding site, the importance of which has previously been overlooked for ligand design against Chk1. It is demonstrated that filling this pocket can confer ligands with dramatically enhanced affinity for Chk1. Structural arguments in conjunction with assay data explain why targeting this pocket is also advantageous for selective binding to Chk1. Structural overlays of known inhibitors complexed with Chk1 show that only the indazole series utilizes the pocket of interest. Therefore, the analysis presented here should prove helpful in guiding future structure-based ligand design efforts against Chk1.